Your browser doesn't support javascript.
loading
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.
Demel, Uta M; Böger, Marlitt; Yousefian, Schayan; Grunert, Corinna; Zhang, Le; Hotz, Paul W; Gottschlich, Adrian; Köse, Hazal; Isaakidis, Konstandina; Vonficht, Dominik; Grünschläger, Florian; Rohleder, Elena; Wagner, Kristina; Dönig, Judith; Igl, Veronika; Brzezicha, Bernadette; Baumgartner, Francis; Habringer, Stefan; Löber, Jens; Chapuy, Björn; Weidinger, Carl; Kobold, Sebastian; Haas, Simon; Busse, Antonia B; Müller, Stefan; Wirth, Matthias; Schick, Markus; Keller, Ulrich.
Affiliation
  • Demel UM; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Böger M; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Yousefian S; Clinician Scientist Program, Berlin Institute of Health (BIH), Berlin, Germany.
  • Grunert C; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Zhang L; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Hotz PW; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gottschlich A; BIH at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Köse H; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Isaakidis K; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Vonficht D; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Grünschläger F; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rohleder E; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Wagner K; Institute of Biochemistry II, Goethe University Frankfurt, Medical School, Frankfurt, Germany.
  • Dönig J; Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, Munich, Germany.
  • Igl V; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Brzezicha B; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Baumgartner F; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Habringer S; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Löber J; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Chapuy B; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Weidinger C; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Kobold S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Haas S; Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Busse AB; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Müller S; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Wirth M; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Schick M; Institute of Biochemistry II, Goethe University Frankfurt, Medical School, Frankfurt, Germany.
  • Keller U; Institute of Biochemistry II, Goethe University Frankfurt, Medical School, Frankfurt, Germany.
J Clin Invest ; 132(9)2022 05 02.
Article in En | MEDLINE | ID: mdl-35499080
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antigen Presentation / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antigen Presentation / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Alemania